Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Price:
10.1 USD
-1.37%
Market Closed
Updated:
May 9, 2024
Phathom Pharmaceuticals Inc
EPS (Diluted)
|
Phathom Pharmaceuticals Inc
EPS (Diluted) Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
|
EPS (Diluted)
-$3
|
CAGR 3-Years
0%
|
CAGR 5-Years
-139%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
EPS (Diluted)
$15
|
CAGR 3-Years
41%
|
CAGR 5-Years
24%
|
CAGR 10-Years
12%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
EPS (Diluted)
-$3
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
EPS (Diluted)
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
EPS (Diluted)
$0
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-5%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
EPS (Diluted)
$6
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
See Also
What is Phathom Pharmaceuticals Inc's EPS (Diluted)?
EPS (Diluted)
-3.9
USD
-3.9
USD
Based on the financial report for Dec 31, 2023, Phathom Pharmaceuticals Inc's EPS (Diluted) amounts to -3.9 USD.
What is Phathom Pharmaceuticals Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-139%
-139%
Over the last year, the EPS (Diluted) growth was 22%.
You don't have any saved screeners yet
